Replies to post #3945 on Gilead Sciences Inc (GILD)

[LionsTact]

The 5 day treatment is their goal now...I'm back in on an upgrade from 15 minutes ago.... ( 5 day treatment instead of the 10 day )

This quote is from 2 days ago

“ These study results offer additional encouraging data for remdesivir, showing that if we can intervene earlier in the disease process with a five-day treatment course, we can significantly improve clinical outcomes for these patients. ”

Heres that (above quote) Link from 2 days ago

https://www.thestreet.com/investing/gilead-positive-trial-results-remdesivir

------------------------------------

Here are Quotes and the " Upgrade " link from 15 minutes ago

" An SVB Leerink analyst upgraded Gilead Sciences (GILD) - Get Report to outperform from market perform, saying sales of the pharmaceutical giant's coronavirus treatment remdesivir could reach $7.7 billion in 2022. "

AND...

" Analyst Geoffrey Porges, who also raised his price target on Gilead Sciences to $94 from $85, said in a note to clients that he expected commercial sales of the drug to be priced at roughly $5,000 per course of treatment in the U.S. and $4,000 in Europe."

https://www.thestreet.com/investing/gilead-shares-upgraded-on-sales-potential-of-coronavirus-drug?tstmem=[userid_]&utm_source=alert&utm_medium=email&utm_campaign=TSC&utm_term=Gilead+Shares+Upgraded+on+Sales+Potential+of+Virus+Drug